CIFoundry
Back to Catalog
Surgery
FDA De Novo (Mar 2018, DEN160044)

Acumen Hypotension Prediction Index (HPI)

Save to shortlist
BD (formerly Edwards Lifesciences Critical Care)

Last reviewed Oct 31, 2026 against the sources listed on this page · How we review

At a glance

Acumen HPI is machine-learning software that analyzes the arterial pressure waveform and gives a 0-100 score for how likely a patient is to become hypotensive (MAP below 65 mmHg) within the next…

FDA:
De Novo DEN160044
Epic:
Not on record
Named users:
Not on record
Published study:
Not on record

Description

Acumen HPI is machine-learning software that analyzes the arterial pressure waveform and gives a 0-100 score for how likely a patient is to become hypotensive (MAP below 65 mmHg) within the next 15 minutes. It also shows hemodynamic parameters that help clinicians judge the likely cause. It received FDA De Novo authorization in 2018 for operating room patients on advanced hemodynamic monitoring and runs on the HemoSphere/EV1000 platform with an Acumen IQ sensor.

HemodynamicsHypotensionOperating room

Quick answers

Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review

Is Acumen Hypotension Prediction Index (HPI) FDA cleared?
The public FDA database has one record that our team matched to Acumen Hypotension Prediction Index (HPI). The most recent is De Novo DEN160044 (Acumen Hypotension Prediction Index (HPI) Feature Software), decided Mar 2018. Check that the cleared use matches how you plan to use it.FDA record DEN160044

Security & contracting

The maker has not reported these details yet. Ask the vendor directly during evaluation.

Workflow stage
Not reported
Integrations
Not reported
Data inputs
Not reported
Deployment
Not reported
Signs a BAA
Not reported
SOC 2 report
Not reported
HITRUST
Not reported
Evidence type
Not assessed

Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.

Who's using this

Organizations named in public announcements or by the developer. Inclusion is not an endorsement.

No public deployments found yet (checked Oct 2026). Using this tool? The maker can claim the listing to add customers.

Get weekly updates for Surgery

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Sources

This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.

Website

FDA database records

  • DEN160044 · De Novo · Mar 2018
    Acumen Hypotension Prediction Index (HPI) Feature Software

Matched by our team from the public FDA database; checked Nov 10, 2026.

History (2)Show

Dated events on this listing's public record, newest first.

  1. Oct 31, 2026

    Added to CIFoundry

  2. Mar 16, 2018

    FDA De Novo DEN160044 decision datesource

Developer

BD (formerly Edwards Lifesciences Critical Care)

Evaluating this tool?

Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.

Prepare evaluation packet

Checklist for your role: Admin · Physician · IT · Compliance

Compare similar tools →

Own this tool?

Claim this listing to update its details and connect with your audience.